ARTICLE
10 March 2026

EuropaBio Will Hold Webinar On Navigating Biotech SME Funding In Europe

BC
Bergeson & Campbell

Contributor

Bergeson & Campbell, P.C. is a Washington D.C. law firm focusing on chemical product approval and regulation, product defense, and associated business issues. The Acta Group, B&C's scientific and regulatory consulting affiliate provides strategic, comprehensive support for global chemical registration, regulation, and sustained compliance. Together, we help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products globally.
On March 10, 2026, EuropaBio, the European Association for Bioindustries, will hold a webinar on "Navigating Biotech SME Funding: What's available, How it works, What's next for Europe."
United States Food, Drugs, Healthcare, Life Sciences
Bergeson & Campbell are most popular:
  • within Finance and Banking, Intellectual Property and Technology topic(s)

On March 10, 2026, EuropaBio, the European Association for Bioindustries, will hold a webinar on "Navigating Biotech SME Funding: What's available, How it works, What's next for Europe." According to EuropaBio, Europe's biotech sector "continues to face significant financing challenges, especially during growth and scale‑up." As the European Union (EU) moves forward with the landmark Biotech Act, the webinar will explore the funding tools available today, how companies can access them, and what changes are needed to expand investment in European biotech. The webinar will provide an overview of current EU public and blended finance options across the development pipeline, explain how the European Investment Bank evaluates and supports biotech projects, and offer first-hand insights from a biotech founder on securing funding from idea to market. It will also examine how upcoming EU initiatives could improve access to capital and attract more private investment. The speakers include:

  • Felicitas Riedl, Director of Innovation and Competitiveness at the European Investment Bank;
  • Raffael Wohlgensinger, Founder and Chief Executive Officer (CEO), Formo; and
  • Jessica Martinsson, moderator and CEO of SwedenBIO, the Swedish Biotech Association.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More